(Quantitative) structure-activity relationships [(Q)SARs] and read-across, together with in vitro tests, must play a key role in the evaluation of the toxicity of chemicals in the proposed European Union (EU) REACH (Registration, Evaluation and Authorisation of Chemicals) programme, if largescale animal testing of chemicals is to be avoided. 1, 2 In the draft EU chemicals legislation on the REACH system (Annex IX from Volume 2 3 ), it is stated that (Q)SARs may be used for the prediction of toxicological properties of chemicals. However, currently, if the results obtained from SAR models indicate the absence of a dangerous property, the relevant animal test must still be carried out to confirm the negative result.
Confirmatory animal testing may be waived, if the following conditions are met:
-the results are derived from validated quantitative or qualitative SAR models;
-the results are adequate for the purpose of classification and labelling, and risk assessment; and -adequate and reliable documentation of the applied method is provided.
Read-across is a process that can be carried out on chemicals with similar chemical/toxicological functionality, by comparing their relative partition or bioavailability parameters (for example, logP [log(octanol-water partition coefficient)], molecular weight). A simple example of read-across would be the prediction of systemic toxicity for members of a homologous series of surfactants. The use of readacross for predicting the toxicity of chemicals is generally accepted by regulatory authorities on a case-by-case basis. Annex IX of the draft proposals 3 allows for toxicological data to be derived by using the "Grouping of substances and read-across approach". This section reads verbatim as follows:
Substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group or 'category' of substances (as they are under the [International Council of Chemical Associations voluntary high production volume programme]). Application of the group concept requires that physicochemical properties, human health effects and environmental effects or environmental fate may be predicted from data for a reference substance within the group by interpolation to other substances in the group (read-across approach). This avoids the need to test every substance for every endpoint.
The similarities may be based on:
(1) a common functional group, (2) the common precursors and/or the likelihood of common breakdown products via physical and biological processes, which result in structurally similar chemicals, or
(3) a constant pattern in the changing of the potency of the properties across the category.
If the group concept is applied, substances shall be classified and labelled on this basis.
In all cases adequate and reliable documentation shall be provided.
A major stumbling block to the use of (Q)SAR models as alternatives to animal tests in the REACH process, is that, so far, not a single (Q)SAR model has been formally validated (for example, according to criteria set out by the European Centre for the Validation of Alternative Methods 4 ). The acceptability criteria for incorporating (Q)SAR models into regulatory processes are under development, 5, 6 but require further refinement prior to agreement at an international level ( Since the validation requirements for (Q)SAR models have yet to be agreed, it is not surprising that none of them have been formally validated. Even when the validation requirements have been agreed, there are other issues that might lead (Q)SAR developers to be reluctant to initiate the validation process, or discourage use of the models for regulatory purposes.
Editorial QSAR, Read-across and REACH
-Unlike animal or in vitro tests, (Q)SAR models are likely to evolve, as new data become available. Models would have to be "frozen" at the time of validation and then "re-validated" at intervals, as they were developed further.
-Unlike animal or in vitro tests, many (Q)SAR models are only applicable to a specific toxicological endpoint for a specific class of chemical, such as the skin corrosivity of phenols. It might not be considered to be cost effective to validate a model with such a narrow range of applicability. It should be stressed, however, that in order to fulfil the "Mechanism criteria" for validation (Table 1) , most (Q)SAR models for toxicity are similarly restricted to these narrow ranges of applicability.
Many (Q)SAR models that have been published in the scientific literature meet the criteria for validation and could already be used for the prediction of the toxicological properties of chemicals within the REACH process. This statement also applies to automated (Q)SAR and knowledge-based expert systems. There is no reason not to use these models as part of the REACH process, provided that the toxicological data used to generate the models are available for use (at the level spec-ified in the "Transparency criteria" for validation; Table 1 ). The REACH process allows the use of readacross of toxicological data from one chemical to another. One of the criteria for a (Q)SAR prediction to be valid is that the candidate chemical must lie within the applicability domain of the model, that is, within the ranges of the descriptors and/or classes of chemicals associated with the proposed mechanism for the model. If the "Applicability domain criteria" (Table 1) for the (Q)SAR model meet those of the candidate chemical, it follows that there will be chemicals within the data set used to generate the model, which will fulfil the criteria laid down in order for a valid read-across process to be carried out.
Read-across can be considered to be (Q)SAR carried out in one dimension (usually bioavailability, as described above). It is accepted because it is transparent and can be easily understood. Therein lies a message for the wider (Q)SAR community.
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Applicability
Applicability domain should be defined appropriately to the model type: ranges of descriptors domain criteria and/or classes of chemicals associated with the proposed mechanism (pathway)
Validation
The (Q)SAR should include a measure of the goodness-of-fit, as well as any results from criteria external validation of the (Q)SAR
Transparency
The (Q)SAR should be accompanied by full access to the data sets, as well as the methods criteria and quality assurance used to generate the data A (Q)SAR specific guidance compendium, to be produced by the developer, should address the acceptability criteria and be quality assured/validated by an independent organisation (for example, ECVAM) before incorporation into a decision support system 
